The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial-Reference-Cited by-同舟云学术

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial

Published:2015-03 Issue:7 Volume:112 Page:1183-1189
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Arnold D T,Hooper C E,Morley A,White P,Lyburn I D,Searle J,Darby M,Hall T,Hall D,Rahman N M,De Winton E,Clive A,Masani V,Dangoor A,Guglani S,Jankowska P,Lowndes S A,Harvey J E,Braybrooke J P,Maskell N A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201577.pdf

Reference25 articles.

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (5): 365–376.

2. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A (5): 635–642.

3. Boons CC, VANT MW, Burgers JA, Beckeringh JJ, Wagner C, Hugtenburg JG (2013) The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review. Anticancer Res 33 (9): 3553–3561.

4. Bottomley A, Gaafar R, Manegold C, Burgers S, Coens C, Legrand C, Vincent M, Giaccone G, Van Meerbeeck J Group EL-C, National Cancer Institute C (2006) Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J Clin Oncol 24 (9): 1435–1442.

5. Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15 (2): 257–260.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in patients with PICC diagnosed with mesothelioma: Results of a multicenter epidemiological survey (LifePICC);The Journal of Vascular Access;2023-10-24

2. Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe;BMC Cancer;2022-06-23

3. Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma;BMC Pulmonary Medicine;2022-04-30

4. Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions;European Respiratory Journal;2021-08-19

5. Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature;Journal of Thoracic Disease;2021-04